+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety



Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety



Expert Opinion on Drug Safety 8(5): 559-571



In patients with native coronary artery disease, strong evidence supports the use of statins to reduce the risk of recurrent cardiovascular events and improve survival. However, for patients undergoing coronary artery bypass graft surgery (CABG), statins appear to be underutilized, and concerns have been raised regarding their perioperative safety. The goal of this systematic review is to evaluate the safety and efficacy of statin therapy before and after coronary surgical revascularization. A systematic review was performed to retrieve relevant articles from the Medline database published between 1987 and January 2009. Administered before CABG, statins have been demonstrated to reduce perioperative mortality, stroke and atrial fibrillation. Preoperative statin therapy also reduces the systemic inflammatory response associated with cardiopulmonary bypass. Following CABG, statins inhibit saphenous vein graft disease and the progression of atherosclerosis in native coronary arteries. In addition, postoperative statins reduce the recurrence of cardiovascular events and improve all-cause mortality. High-intensity lipid reduction to achieve low-density lipoprotein levels to 70 mg/dl may benefit post-CABG patients, but this has yet to be evaluated prospectively. Adverse effects related to perioperative statin therapy seem to be extremely rare, and little data are available to support the practice of withholding statin therapy before or after surgery. Numerous studies have demonstrated that statins improve the outcomes of patients undergoing CABG. The benefits seem to outweigh the risks associated with their use, both in the preoperative and postoperative period. In the absence of contraindications, essentially all CABG patients are candidates for life-long statin therapy that ideally should be started before surgery. The optimal postoperative statin regimen remains unknown and should be the subject of future study.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911720

Download citation: RISBibTeXText

PMID: 19673591

DOI: 10.1517/14740330903188413


Related references

Safety and Efficacy of Dexmedetomidine for Postoperative Sedation after Coronary Artery Bypass Graft Surgery. Anesthesiology Abstracts of Scientific Papers Annual Meeting ( ): Abstract No A-56, 2002

Postoperative delirium and short-term cognitive dysfunction occur more frequently in patients undergoing valve surgery with or without coronary artery bypass graft surgery compared with coronary artery bypass graft surgery alone: results of a pilot study. Journal of Cardiothoracic and Vascular Anesthesia 25(5): 811-816, 2012

Preoperative determinants of postoperative costs associated with coronary artery bypass graft surgery. Circulation 90(5 Pt 2): Ii124-8, 1994

Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the preoperative aspirin and postoperative antiplatelets in coronary artery bypass grafting surgery. American Heart Journal 161(5): E25; Author Reply E27-E25; Author Reply E27, 2011

Effect of a preoperative intervention on preoperative and postoperative outcomes in low-risk patients awaiting elective coronary artery bypass graft surgery. A randomized, controlled trial. Annals of Internal Medicine 133(4): 253-262, 2000

Preoperative and postoperative stress evaluation in the assessment of coronary artery bypass graft surgery. Cleveland Clinic Quarterly 45(1): 121-122, 1978

Preoperative diagnosis and postoperative prognosis in patients undergoing coronary artery bypass graft surgery. American Heart Journal 171(1): E9-E9, 2016

The safety of preoperative vardenafil in patients undergoing coronary artery bypass graft surgery. Journal of Cardiovascular Pharmacology 62(1): 106-109, 2013

Safety and efficacy of glucose-insulin-potassium treatment in coronary artery bypass graft surgery and percutaneous coronary intervention. Interactive Cardiovascular and Thoracic Surgery 21(5): 667-676, 2015

Antiplatelet therapy and coronary artery bypass graft surgery: perioperative safety and efficacy. Expert Opinion on Drug Safety 8(2): 169-182, 2009

Preoperative statin administration is associated with lower mortality and decreased need for postoperative hemodialysis in patients undergoing coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia 23(4): 468-473, 2009

The effect of preoperative circadian blood pressure pattern on early postoperative outcomes in patients with coronary artery bypass graft surgery. Anadolu Kardiyoloji Dergisi 8(5): 354-359, 2008

Prediction of postoperative pulmonary complications on the basis of preoperative risk factors in patients who had undergone coronary artery bypass graft surgery. Physical Therapy 83(1): 8-16, 2002

Postoperative atrial fibrillation: a comparison of off-pump coronary artery bypass surgery and conventional coronary artery bypass graft surgery. Journal of Cardiothoracic and Vascular Anesthesia 16(2): 144-148, 2002

Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery. American Heart Journal 162(5): 836-843, 2012